Periconceptional Maternal Folic Acid Use of 400 µg per Day Is Related to Increased Methylation of the IGF2 Gene in the Very Young Child

Régine P. Steegers-Theunissen, Sylvia A. Obermann-Borst, Dennis Kremer et al. · 2009

Read Periconceptional Maternal Folic Acid Use of 400 µg per Day Is Related to Increased Methylation of the IGF2 Gene in the Very Young Child by Régine P. Steegers-Theunissen, Sylvia A. Obermann-Borst, Dennis Kremer et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0007845.txt.

Description

Regine Steegers-Theunissen and co-authors published a study in PLOS ONE in 2009. It links a mother's folic acid use around conception to chemical marks in her child. Countries advise women planning pregnancy to take folic acid daily. The supplement prevents serious birth defects.

How it protects is not fully clear, but epigenetic changes are suspected. The authors measured methylation of the growth gene IGF2 in very young children. Children whose mothers used folic acid showed increased methylation. The finding ties a routine supplement to lasting marks on a child's genes. It may help explain folic acid's protective effect.

Catalog record

CREATORRégine P. Steegers-Theunissen, Sylvia A. Obermann-Borst, Dennis Kremer et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE30 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007845

Browse the full library · About the Tower of Babel